Patents by Inventor Linyan Meng

Linyan Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of UBE3A-ATS expression
    Patent number: 9617539
    Abstract: Certain embodiments are directed to methods and compounds for inhibiting UBE3A-ATS, the endogenous antisense transcript of ubiquitin protein ligase E3A (UBE3A). Such methods and compounds are useful for inducing expression of paternal UBE3A in cells and animals.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: April 11, 2017
    Assignees: Ionis Pharmaceuticals, Inc., Baylor College of Medicine
    Inventors: Frank Rigo, Amanda Ward, Linyan Meng, Arthur L. Beaudet
  • MODULATION OF UBE3A-ATS EXPRESSION
    Publication number: 20150191723
    Abstract: Certain embodiments are directed to methods and compounds for inhibiting UBE3A-ATS, the endogenous antisense transcript of ubiquitin protein ligase E3A (UBE3A). Such methods and compounds are useful for inducing expression of paternal UBE3A in cells and animals.
    Type: Application
    Filed: June 25, 2013
    Publication date: July 9, 2015
    Applicants: Baylor College of Medicine, Isis Pharmaceuticals, Inc.
    Inventors: Frank Rigo, Amanda Ward, Linyan Meng, Arthur L. Beaudet